Rankings
▼
Calendar
BCYC Q4 2017 Earnings — Bicycle Therapeutics plc Revenue & Financial Results | Market Cap Arena
BCYC
Bicycle Therapeutics plc
$360M
Q4 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$655,000
Gross Profit
-$3M
-526.7% margin
Operating Income
-$6M
-919.1% margin
Net Income
-$6M
-889.3% margin
EPS (Diluted)
$-0.38
Cash Flow
Operating Cash Flow
-$1M
Free Cash Flow
-$2M
Stock-Based Comp.
$270,000
Balance Sheet
Total Assets
$74M
Total Liabilities
$9M
Stockholders' Equity
$49M
Cash & Equivalents
$68M
← FY 2017
All Quarters
Q1 2018 →